Research programme: Alzheimer's disease therapeutics - Clera

Drug Profile

Research programme: Alzheimer's disease therapeutics - Clera

Alternative Names: CLR 097

Latest Information Update: 21 Jan 2014

Price : $50

At a glance

  • Originator Clera
  • Class
  • Mechanism of Action Amyloid beta-protein inhibitors; Amyloid beta-protein precursor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Alzheimer's disease

Most Recent Events

  • 01 Jan 2014 Early research in Alzheimer's disease in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top